Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders
- Authors
- Chi, Suhyuk; Lee, Moon-Soo
- Issue Date
- 2월-2021
- Publisher
- MDPI
- Keywords
- cytokines; neuroimmunology; depression; machine learning
- Citation
- JOURNAL OF PERSONALIZED MEDICINE, v.11, no.2, pp.1 - 14
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF PERSONALIZED MEDICINE
- Volume
- 11
- Number
- 2
- Start Page
- 1
- End Page
- 14
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/129258
- DOI
- 10.3390/jpm11020114
- ISSN
- 2075-4426
- Abstract
- Major depressive disorder (MDD) is associated with increased suicidal risk and reduced productivity at work. Neuroimmunology, the study of the immune system and nervous system, provides further insight into the pathogenesis and outcome of MDD. Cytokines are the main modulators of neuroimmunology, and their levels are somewhat entangled in depressive disorders as they affect depressive symptoms and are affected by antidepressant treatment. The use of cytokine-derived medication as a treatment option for MDD is currently a topic of interest. Although not very promising, cytokines are also considered as possible prognostic or diagnostic markers for depression. The machine learning approach is a powerful tool for pattern recognition and has been used in psychiatry for finding useful patterns in data that have translational meaning and can be incorporated in daily clinical practice. This review focuses on the current knowledge of neuroimmunology and depression and the possible use of machine learning to widen our understanding of the topic.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Life Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.